Cargando…

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report

BACKGROUND: Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma (Xp11.2 RCC) exhibits unique biological characteristics and is associated with an increased incidence of tumor thrombosis, lymph node metastasis, and advanced disease stages. Multimodality imaging, including US, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wenpeng, Peng, Yushuo, Zhang, Yongbai, Qiu, Yongkang, Liu, Yi, Wang, Aixiang, Kang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546202/ https://www.ncbi.nlm.nih.gov/pubmed/37795411 http://dx.doi.org/10.3389/fmed.2023.1266630

Ejemplares similares

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Wang, Wei, et al.
Publicado: (2014)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature
por: Ahluwalia, Puneet, et al.
Publicado: (2013)

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015)

Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature
por: Parikh, Jigarkumar, et al.
Publicado: (2009)

Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature
por: Gong, Pengfeng, et al.
Publicado: (2018)

Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022)

Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
por: Cheng, Xiangming, et al.
Publicado: (2016)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma
por: Cheng, Jun, et al.
Publicado: (2020)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Xp11.2 translocation renal cell carcinomas in young adults
por: Xu, Linfeng, et al.
Publicado: (2015)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature
por: Miroński, Ignacy, et al.
Publicado: (2022)

The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma
por: Naviwala, Mohammad Saad, et al.
Publicado: (2023)

TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas
por: Yin, Xiaoqin, et al.
Publicado: (2019)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

Alpha-fetoprotein-elevated postpubertal testicular teratoma with retroperitoneal metastasis on (18)F-FDG PET/CT: case report and literature review
por: Jiao, Hao, et al.
Publicado: (2023)

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma
por: Pradhan, Dinesh, et al.
Publicado: (2015)

Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics
por: Dey, Biswajit, et al.
Publicado: (2016)

Multimodality imaging evaluation of nasal sinus alveolar rhabdomyosarcoma: Two case reports
por: Huang, Wenpeng, et al.
Publicado: (2022)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
por: Guo, Wei, et al.
Publicado: (2023)

Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
por: Wei, Shuping, et al.
Publicado: (2019)

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
por: Zhao, Juping, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma
por: Kalita, Pranjal, et al.
Publicado: (2023)

Bilateral Xp11.2 translocation renal cell carcinoma: a case report
por: Karashima, Takashi, et al.
Publicado: (2018)

Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma
por: Lu, Yanwen, et al.
Publicado: (2023)

Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype
por: Kmetec, Andrej, et al.
Publicado: (2014)

Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors
por: Dong, Jie, et al.
Publicado: (2021)

Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report
por: Morii, Akihiro, et al.
Publicado: (2012)

Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review
por: Wang, Yuxiong, et al.
Publicado: (2020)

Primary renal myxoid liposarcoma with pancreatic invasion on (18)F-FDG PET/CT: first case report and literature review
por: Huang, Wenpeng, et al.
Publicado: (2023)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
por: Zhang, Huizhi, et al.
Publicado: (2023)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report
por: Kanas, Alexandre Fligelman, et al.
Publicado: (2020)

A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults
por: Shi, Qiancheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpehndo2f590mtugautdebetbk